Rolf Guenter Werner
Director/Board Member at Vakzine Projekt Management GmbH
Profile
Rolf Guenter Werner is currently a Member-Scientific Board at Universität Stuttgart since 1990 and a Member-Supervisory Board at Vakzine Projekt Management GmbH since 2012.
Previously, he held positions as a Director at Avesthagen Ltd.
and Kemwell Biopharma Pvt Ltd., as well as Senior Vice President at Boehringer Ingelheim GmbH.
He also served as a Member-Scientific Board at Fraunhofer-Gesellschaft eV.
Dr. Werner obtained a doctorate degree from Eberhard Karls Universität Tübingen in 1973 and a graduate degree in 1971.
Rolf Guenter Werner active positions
Companies | Position | Start |
---|---|---|
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Director/Board Member | 2009-11-15 |
Universität Stuttgart | Corporate Officer/Principal | 1989-12-31 |
Former positions of Rolf Guenter Werner
Companies | Position | End |
---|---|---|
Fraunhofer-Gesellschaft eV
Fraunhofer-Gesellschaft eV Miscellaneous Commercial ServicesCommercial Services Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. operates as an application-oriented research organization. The firm focuses on health, security, communication, as well as environment and energy. It develops technology, designs products, and improves methods and techniques. The company was founded on March 26, 1949 and is headquartered in Munich, Germany. | Corporate Officer/Principal | - |
Avesthagen Ltd.
Avesthagen Ltd. Miscellaneous Commercial ServicesCommercial Services Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India. | Director/Board Member | - |
Kemwell Biopharma Pvt Ltd.
Kemwell Biopharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Kemwell Biopharma Pvt Ltd. provides bio/pharmaceutical contract pharmaceutical development and manufacturing services. It delivers a portfolio of services for sterile and non-sterile products from preformulation to commercial supply. The firm offers formulation development, analytical support, clinical batch production, commercial-scale manufacturing, packing or global supply chain services. The company was founded in 1980 and is headquartered in Bangalore, India. | Director/Board Member | - |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - |
Training of Rolf Guenter Werner
Eberhard Karls Universität Tübingen | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Avesthagen Ltd.
Avesthagen Ltd. Miscellaneous Commercial ServicesCommercial Services Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India. | Commercial Services |
Kemwell Biopharma Pvt Ltd.
Kemwell Biopharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Kemwell Biopharma Pvt Ltd. provides bio/pharmaceutical contract pharmaceutical development and manufacturing services. It delivers a portfolio of services for sterile and non-sterile products from preformulation to commercial supply. The firm offers formulation development, analytical support, clinical batch production, commercial-scale manufacturing, packing or global supply chain services. The company was founded in 1980 and is headquartered in Bangalore, India. | Health Technology |
Fraunhofer-Gesellschaft eV
Fraunhofer-Gesellschaft eV Miscellaneous Commercial ServicesCommercial Services Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. operates as an application-oriented research organization. The firm focuses on health, security, communication, as well as environment and energy. It develops technology, designs products, and improves methods and techniques. The company was founded on March 26, 1949 and is headquartered in Munich, Germany. | Commercial Services |
- Stock Market
- Insiders
- Rolf Guenter Werner